Table 1.
All participants | Responders ~ 4 years post-baseline | |||
---|---|---|---|---|
Intervention n = 119 | Usual care n = 118 | Intervention n = 70 | Usual care n = 58 | |
Socio-demographical factors | ||||
Age (years) | 50.9 ± 9.0 | 50.6 ± 8.6 | 51.1 ± 8.3 | 51.6 ± 7.9 |
Sex, female | 109 (91.6) | 107 (90.7) | 64 (91.4) | 53 (91.4) |
Marital status | ||||
Couple | 91 (76.5) | 87 (73.7) | 59 (84.3) | 48 (82.8) |
Single | 24 (20.2) | 25 (21.2) | 11 (15.7) | 10 (17.2) |
Education | ||||
Low | 5 (4.2) | 21 (17.8) | 2 (2.9) | 8 (13.8) |
Medium | 55 (46.2) | 46 (39.0) | 36 (51.4) | 22 (37.9) |
High | 55 (46.2) | 45 (38.1) | 32 (45.7) | 28 (48.3) |
BMI (kg/m2) | 25.9 ± 4.4 | 26.5 ± 5.0 | 25.4 ± 4.0 | 25.6 ± 4.2 |
Postmenopausal | 48 (40.3) | 36 (30.5) | 27 (38.6) | 17 (29.3) |
Cancer-related factors | ||||
Tumor site | ||||
Breast cancer | 102 (85.7) | 102 (86.4) | 59 (84.3) | 51 (87.9) |
Colon cancer | 17 (14.3) | 16 (13.6) | 11 (15.7) | 7 (12.1) |
Radiotherapy | ||||
Yes | 74 (62.2) | 71 (60.2) | 46 (65.7) | 34 (58.6) |
No | 45 (37.8) | 47 (39.8) | 24 (34.3) | 24 (41.4) |
Tumor receptor status | ||||
Triple negative | 24 (20.2) | 12 (10.2) | 13 (18.6) | 6 (10.3) |
Her2+, ER+ or PR+ | 11 (9.2) | 18 (15.3) | 6 (7.1) | 10 (17.2) |
Her2+, ER– and PR– | 10 (8.4) | 2 (1.7) | 9 (12.9) | – |
Her2–, ER+ or PR+ | 57 (47.9) | 70 (59.3) | 32 (45.7) | 35 (60.3) |
Tissue expander | 9 (7.6) | 10 (8.5) | 5 (7.1) | 5 (8.6) |
Median | Median | Median | Median | |
Moderate-to-high intensity total PA performed before diagnosis (min/week) | 485 [240–975] | 600 [300–1440] | 450 [233–1005] | 720 [375–1540] |
Moderate -to-high intensity leisure and sport PA levels performed before diagnosis (min/week) | 180 [50–375] | 173 [60–330] | 180 [60–315] | 180 [60–345] |
Continuous variables are presented as mean ± SD or as median and interquartile range, whereas dichotomous or categorical variables are presented as n (%)
BMI body mass index, ER estrogen receptor, PR progesterone receptor, PA physical activity, SD standard deviation